Back
Halozyme Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
HALO
Halozyme Therapeutics
Last Price:
$58.80
Seasonality Move:
8.07%
7 Day Trial
ALL ACCESS PASS
$
7
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.62 | Sell |
| 20-day SMA: | 61.89 | Sell |
| 50-day SMA: | 60.18 | Sell |
| 200-day SMA: | 55.72 | Buy |
| 8-day EMA: | 60.18 | Sell |
| 20-day EMA: | 60.82 | Sell |
| 50-day EMA: | 59.69 | Sell |
| 200-day EMA: | 54.51 | Buy |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 44.13 | Sell |
| Chaikin Money Flow: | -521118 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.86 - 64.22) | Sell |
| Bollinger Bands (100): | (49.23 - 61.11) | Buy |
Halozyme Therapeutics Technical Analysis
| Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 58.82 while HALO 8-day simple moving average is 59.62, which is a Sell signal.
-
The stock price of HALO is 58.82 while Halozyme Therapeutics 20-day SMA is 61.89, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 60.18 while HALO share price is 58.82, making it a Sell technically.
-
HALO stock price is 58.82 and Halozyme Therapeutics 200-day simple moving average is 55.72, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
57
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $58.82. The Score for HALO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
7.2B
Price in USD:
58.82
Share Volume:
1.7M
Halozyme Therapeutics 52-Week Range
52-Week High:
66.00
52-Week Low:
37.73
Buy
57
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 58.82 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 58.82 while HALO 8-day exponential moving average is 60.18, which is a Sell signal.
-
The stock price of HALO is 58.82 while Halozyme Therapeutics 20-day EMA is 60.82, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 59.69 while HALO share price is 58.82, making it a Sell technically.
-
HALO stock price is 58.82 and Halozyme Therapeutics 200-day simple moving average is 54.51, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.77 per share, and an increase next year of $1.51 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 44.13, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (59.86 - 64.22), which suggest Halozyme Therapeutics is a Buy
-
The Bollinger Bands (100) for Halozyme Therapeutics is (49.23 - 61.11), which suggest Halozyme Therapeutics is a Buy
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.